Our findings seem to support the data obtained in a study aimed at exploring whether ubiquitin-activating enzyme E1, ubiquitin-conjugating enzyme E2, and ubiquitin or proteasome activity are affected in peripheral blood mononuclear cells (PBMC) of AD and MCI subjects compared to healthy controls. The gene discussed is UBE2E2; the disease is Alzheimer disease.